Form 4: Bayview Legacy Sells Arteris Shares via 10b5-1 Plan

Bayview Legacy, LLC, a 10% owner of Arteris, Inc., reported the sale of 50,000 common shares through a pre-arranged 10b5-1 trading plan.

Summary

• Bayview Legacy, LLC, identified as a 10% owner of Arteris, Inc. (AIP), reported the sale of 50,000 shares of common stock.
• The transaction occurred on August 5, 2025, and was executed pursuant to a Rule 10b5-1 trading plan adopted on March 5, 2025.
• The shares were sold at a weighted average price of $13.1199, with individual sales prices ranging from $12.35 to $14.20.
• Following this transaction, Bayview Legacy, LLC indirectly beneficially owns 9,839,071 shares of Arteris, Inc.
• K. Charles Janac, the manager of Bayview Legacy, LLC, also filed a separate Form 4 on the same date, reporting the identical transaction due to his beneficial ownership and control over the shares.

Sentiment

Score: 6

Explanation: The sale of 50,000 shares by a 10% owner, Bayview Legacy, LLC, represents a very small fraction (approximately 0.5%) of their total beneficial ownership in Arteris, Inc. The transaction was executed under a pre-arranged 10b5-1 trading plan, indicating a scheduled, non-discretionary sale rather than a reactive decision based on new information. While any insider sale can be perceived negatively, the small volume and pre-planned nature mitigate significant negative sentiment.

Negatives

• A 10% owner, Bayview Legacy, LLC, sold 50,000 shares of common stock, which could be perceived as a slight negative signal by some investors, despite being pre-planned.

Risks

• The sale of shares by a significant owner, even if pre-planned, could potentially lead to negative market sentiment or speculation regarding the company's future performance.

Future Outlook

This Form 4 filing reports a past transaction and does not contain any forward-looking statements or guidance regarding Arteris, Inc.'s future performance or outlook.

Management Comments

• K. Charles Janac is the manager of Bayview Legacy, LLC and is deemed to have voting and dispositive power over the shares beneficially owned by Bayview Legacy, LLC.
• K. Charles Janac, in his individual capacity, has separately filed a Form 4 reporting the same transaction given his beneficial ownership of the reported security through Bayview Legacy, LLC, which he controls as its manager.

Industry Context

Form 4 filings are routine disclosures for insiders of publicly traded companies, reporting changes in their beneficial ownership. The use of a Rule 10b5-1 trading plan for such transactions is a common practice, allowing insiders to pre-arrange sales or purchases to avoid accusations of trading on material non-public information.

Related Party Transactions

• The transaction involves Bayview Legacy, LLC, a 10% owner of Arteris, Inc., which is managed and controlled by K. Charles Janac, who also filed a separate Form 4 for the same transaction, indicating a related party dealing.

Stakeholder Impact

• Shareholders might interpret the sale by a significant owner as a minor negative signal, potentially leading to a slight decrease in investor confidence, although the pre-planned nature and small volume mitigate this impact.

Key Dates

Recommendation

The reported sale by Bayview Legacy, LLC, a 10% owner, is a minor transaction representing a very small percentage of their total holdings and was conducted under a pre-arranged 10b5-1 plan. This suggests a routine portfolio management activity rather than a signal of diminished confidence in Arteris, Inc.'s future prospects. Investors should consider this transaction as a neutral data point and focus on the company's fundamental performance and broader market conditions for investment decisions.

Keywords

Arteris, AIP, Bayview Legacy, K. Charles Janac, Form 4, Insider Trading, Stock Sale, 10b5-1 Plan, Beneficial Ownership